speb/financial-data huggingface dataset:
Financial ratios for WKHS — quarterly report dated 2025-12-31
Total revenue: 13433561
Gross profit: 10058354
Operating income: -3574406
Net income: -20833000
Capital expenditures: 0
Operating cash flow: -10538538
Depreciation & amortization: -4351275
Net tangible assets: 29730000
Owner earnings: -25184275
Return on net tangible assets (%): -84.70997309115371
Buffett classification: The Gruesome
Stock price: 5.09
Shares outstanding: 10893400
Book value: 43042000
P/B ratio: 1.28821630035779
Market cap (USD): 55447406
Debt to equity: 0.8787231076622833
Current ratio: 1.5397405538968394
Quick ratio: 0.25378358900442705
COGS to revenue (%): 18.291925722449914
R&D to revenue (%): 69.30405124895775
SG&A to revenue (%): 32.17879458767485
Free cash flow (dilution-adjusted): -10250726
Buyback yield (%): 0
Retained earnings: -319023000
Inventory turnover: 0.04918251871422281
Receivables turnover: 3.4542455644124455
Capitalized R&D asset: 10443309.61
ROCI (R&D-adjusted, %): 2.0759204609545883
Rosenberg metric: 16.486144143960225
FCF margin (%): -76.30684075503137
Revenue growth (%): 463.25250587212236
Rule of 40 score: 386.945665117091
Financial ratios for ZENA.OL — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.13668224299065418
Shares outstanding: 714756457
Market cap (USD): 97694515.73481306
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZENA.OL — annual report dated 2023-03-31
Total revenue: 2053382.6444444442
Gross profit: -5722172.911111111
Operating income: -14494765.503703702
Net income: -9501481.481481481
Capital expenditures: 318518.5185185185
Operating cash flow: -11736296.296296295
Depreciation & amortization: 3516296.296296296
Net tangible assets: 67890370.37037037
Owner earnings: -6303703.703703703
Return on net tangible assets (%): -9.285121983153667
Buffett classification: The Gruesome
Stock price: 0.068334937439846
Shares outstanding: 714756457
Book value: 67890370.37037036
P/B ratio: 0.7194369025734119
Market cap (USD): 48842837.77382098
Debt to equity: 0.3703574390084232
Current ratio: 1.1093780088580782
Quick ratio: 0.9024327620514796
Interest coverage ratio: -7.079570705499276
COGS to revenue (%): 378.6705598487846
SG&A to revenue (%): 314.92750190339046
Free cash flow (dilution-adjusted): -12597777.777777776
Buyback yield (%): 0
Retained earnings: 12440740.74074074
Inventory turnover: 1.6279466501240696
Receivables turnover: 0.23551967459643158
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.443443420365648
FCF margin (%): -613.513404910763
Rule of 40 score: -613.513404910763
Financial ratios for ZENA.OL — annual report dated 2024-03-31
Total revenue: 1324444.4444444443
Gross profit: -2396296.296296296
Operating income: -10608888.888888888
Net income: -31382962.962962963
Capital expenditures: 39259.259259259255
Operating cash flow: -3103703.7037037034
Depreciation & amortization: 2917037.037037037
Net tangible assets: 36620740.74074074
Owner earnings: -28505185.185185183
Return on net tangible assets (%): -77.83890934099276
Buffett classification: The Gruesome
Stock price: 0.03255813953488372
Shares outstanding: 714756457
Book value: 37020740.74074074
P/B ratio: 0.6285973752776803
Market cap (USD): 23271140.460465115
Debt to equity: 0.8340469806714954
Current ratio: 0.2997610513739546
Quick ratio: 0.17843488649940262
Interest coverage ratio: -2.8598242811501597
COGS to revenue (%): 280.92841163310965
SG&A to revenue (%): 499.8322147651008
Free cash flow (dilution-adjusted): -3142962.9629629627
Buyback yield (%): 0
Retained earnings: -20011851.85185185
Inventory turnover: 2.4731659281142298
Receivables turnover: 1.8781512605042014
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.61764467301546
FCF margin (%): -237.30425055928413
Revenue growth (%): -35.4993844898898
Rule of 40 score: -272.8036350491739
Financial ratios for ZENA.OL — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 39808148.14814815
Buffett classification: The Gruesome
Stock price: 0.017175572519083967
Shares outstanding: 714756457
Book value: 39808148.14814815
P/B ratio: 0.308387903777888
Market cap (USD): 12276351.360687021
Debt to equity: 0.9012671889246571
Current ratio: 0.8307052503898804
Quick ratio: 0.7102177554438861
Buyback yield (%): 0
Retained earnings: -17224444.444444444
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZENA.OL — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 45894405.5944056
Buffett classification: The Gruesome
Stock price: 0.09732824427480916
Shares outstanding: 714756457
Book value: 45894405.59440559
P/B ratio: 1.5157836808844745
Market cap (USD): 69565991.04389313
Debt to equity: 0.7389568635816484
Current ratio: 1.313241493198905
Quick ratio: 1.2084220590152535
Buyback yield (%): 0
Retained earnings: -21025874.12587413
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ZENA.OL — annual report dated 2025-03-31
Total revenue: 1501398.6013986014
Gross profit: 55944.055944055945
Operating income: -2853846.153846154
Net income: 761538.4615384616
Capital expenditures: 869930.06993007
Operating cash flow: -7668531.468531469
Depreciation & amortization: 255944.05594405596
Net tangible assets: 45894405.5944056
Owner earnings: 147552.44755244756
Return on net tangible assets (%): 0.32150421307653626
Buffett classification: The Gruesome
Stock price: 0.09732824427480916
P/E ratio: 91.34928116874853
Shares outstanding: 714756457
Book value: 45894405.59440559
P/B ratio: 1.5157836808844745
Market cap (USD): 69565991.04389313
Debt to equity: 0.7389568635816484
Current ratio: 1.313241493198905
Quick ratio: 1.2084220590152535
Effective tax rate (%): 0
Interest coverage ratio: -1.6258964143426293
COGS to revenue (%): 96.27387051700046
SG&A to revenue (%): 122.86911970190964
Free cash flow (dilution-adjusted): -10565034.965034965
Buyback yield (%): 0
Retained earnings: -21025874.12587413
Inventory turnover: 0.8569651741293531
Receivables turnover: 1.7080350039777248
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8799469316321344
FCF margin (%): -703.679552864462
Revenue growth (%): 13.360632655934687
Rule of 40 score: -690.3189202085274
Financial ratios for ZENA.OL — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 54321582.73381295
Buffett classification: The Gruesome
Stock price: 0.047094188376753505
Shares outstanding: 714756457
Book value: 54321582.73381296
P/B ratio: 0.61965932388981
Market cap (USD): 33660875.22945891
Debt to equity: 0.7077224628180169
Current ratio: 1.2202958924250313
Quick ratio: 1.1438110699298558
Buyback yield (%): 0
Retained earnings: -20669784.17266187
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2372.HK — annual report dated 2021-12-31
Total revenue: 58133594.97645212
Gross profit: 12839717.425431712
Operating income: 6549921.507064364
Net income: 5602354.788069074
Capital expenditures: 42543.17111459969
Operating cash flow: 4494191.522762951
Depreciation & amortization: 543485.0863422292
Net tangible assets: 15351334.379905809
Owner earnings: 6103296.703296704
Return on net tangible assets (%): 39.75743445003477
Capex to operating income (%): 0.6495218464635812
Buffett classification: The Great
Shares outstanding: 800000000
Book value: 15855102.04081633
Debt to equity: 0.09960691901739653
Current ratio: 1.3876144268060986
Quick ratio: 1.1253997414438321
Effective tax rate (%): 15.168298944565938
Interest coverage ratio: 50.57333333333333
COGS to revenue (%): 77.9134295227525
R&D to revenue (%): 3.541617721320728
SG&A to revenue (%): 11.480080256865174
Free cash flow (dilution-adjusted): 4294034.536891679
Retained earnings: 3738461.5384615385
Inventory turnover: 5.759037106529073
Receivables turnover: 2.552531087154319
Capitalized R&D asset: 2058869.7017268445
ROCI (R&D-adjusted, %): 43.58812690735301
FCF margin (%): 7.386494054997016
Rule of 40 score: 7.386494054997016
Financial ratios for 2522.HK — annual report dated 2022-12-31
Total revenue: 112707471.26436782
Gross profit: 34044540.22988506
Operating income: 6167097.7011494255
Net income: 52298.85057471265
Capital expenditures: 37334051.72413793
Operating cash flow: 28472557.47126437
Depreciation & amortization: 24365373.563218392
Net tangible assets: 177937500
Owner earnings: -12916379.310344826
Return on net tangible assets (%): -7.258941656674296
Capex to operating income (%): 605.3747408149477
Buffett classification: The Gruesome
Shares outstanding: 288391574
Book value: 189114798.85057467
Debt to equity: 0.36704656221248577
Current ratio: 1.8465031125974576
Quick ratio: 1.8296709108124987
Effective tax rate (%): 1710.4812834224604
Interest coverage ratio: 1.1495795168461085
COGS to revenue (%): 69.79389223449985
R&D to revenue (%): 1.4638393562829213
SG&A to revenue (%): 8.979481008204537
Free cash flow (dilution-adjusted): -11017097.701149426
Retained earnings: -70726724.13793103
Inventory turnover: 81.91113105924596
Receivables turnover: 2.846406450138067
Capitalized R&D asset: 1649856.3218390804
ROCI (R&D-adjusted, %): 3.1536460687760255
FCF margin (%): -9.774948880990868
Rule of 40 score: -9.774948880990868
Financial ratios for 2522.HK — annual report dated 2023-12-31
Total revenue: 130648945.14767931
Gross profit: 46778762.306610405
Operating income: 11252883.263009844
Net income: 6246835.443037975
Capital expenditures: 12640646.976090014
Operating cash flow: 28331223.628691982
Depreciation & amortization: 26445991.561181433
Net tangible assets: 175000843.88185653
Owner earnings: 20052180.028129395
Return on net tangible assets (%): 11.458333333333334
Capex to operating income (%): 112.33251674832519
Buffett classification: The Gruesome
Shares outstanding: 288391574
Book value: 187779746.83544302
Debt to equity: 0.2891281193965459
Current ratio: 1.9623984768362723
Quick ratio: 1.9455317157098397
Effective tax rate (%): 15.691201217122705
Interest coverage ratio: 3.227300229922149
COGS to revenue (%): 64.19507080310987
R&D to revenue (%): 1.3826898937899526
SG&A to revenue (%): 26.615703929534916
Free cash flow (dilution-adjusted): 14390717.299578058
Retained earnings: -62987763.71308017
Inventory turnover: 111.81642602662666
Receivables turnover: 2.7976977845241966
Capitalized R&D asset: 2911873.4965323247
ROCI (R&D-adjusted, %): 5.347505976553378
Rosenberg metric: 7.7183824483156345
FCF margin (%): 11.014797925319243
Revenue growth (%): 15.918619841294982
Rule of 40 score: 26.933417766614227
Financial ratios for 2590.HK — annual report dated 2022-12-31
Total revenue: 208644109.1954023
Gross profit: 36860344.827586204
Operating income: -120425143.67816092
Net income: -225159195.40229884
Capital expenditures: 5145833.333333333
Operating cash flow: -93269396.55172414
Depreciation & amortization: 17952873.563218392
Net tangible assets: -623134482.7586207
Owner earnings: -212352155.1724138
Buffett classification: The Gruesome
Shares outstanding: 1005950483
Book value: -621812500
Debt to equity: -0.0633668490912851
Current ratio: 0.42101782101647334
Quick ratio: 0.26741930367362465
Interest coverage ratio: -67.12252742852567
COGS to revenue (%): 82.33338819402505
R&D to revenue (%): 30.0784416074504
SG&A to revenue (%): 10.742940014309688
Free cash flow (dilution-adjusted): -100484482.75862068
Retained earnings: -370754022.9885057
Inventory turnover: 1.0086913751895068
Receivables turnover: 3.6712037516906624
Capitalized R&D asset: 62756896.551724136
FCF margin (%): -48.16070923167716
Rule of 40 score: -48.16070923167716
Financial ratios for 2590.HK — annual report dated 2023-12-31
Total revenue: 301396202.53164554
Gross profit: 92724894.51476793
Operating income: -67096343.17862166
Net income: -158464556.9620253
Capital expenditures: 6496061.884669479
Operating cash flow: -67148523.20675105
Depreciation & amortization: 12363009.845288325
Net tangible assets: -767172292.5457102
Owner earnings: -152597609.00140646
Buffett classification: The Gruesome
Shares outstanding: 1005950483
Book value: -765550773.5583684
Debt to equity: -0.08612554027454379
Current ratio: 0.36941282151050786
Quick ratio: 0.2347835349440252
Interest coverage ratio: -35.91199939777176
COGS to revenue (%): 69.23488294281607
R&D to revenue (%): 17.726782106903315
SG&A to revenue (%): 9.406806671435843
Free cash flow (dilution-adjusted): -76862165.96343178
Retained earnings: -521396765.11954993
Inventory turnover: 1.2461410148513605
Receivables turnover: 2.9340976212872403
Capitalized R&D asset: 95474968.79092099
Rosenberg metric: 0.890173873418649
FCF margin (%): -25.502035300315878
Revenue growth (%): 44.4546906662856
Rule of 40 score: 18.952655365969722
Financial ratios for 2590.HK — annual report dated 2024-12-31
Total revenue: 330001506.84931505
Gross profit: 114680410.95890412
Operating income: -13686575.342465755
Net income: -113904246.57534246
Capital expenditures: 13246438.356164385
Operating cash flow: -14808356.164383562
Depreciation & amortization: 8559041.09589041
Net tangible assets: -857717123.2876712
Owner earnings: -118591643.83561642
Buffett classification: The Gruesome
Shares outstanding: 1005950483
Book value: -855999863.0136988
Debt to equity: -0.07171586091983434
Current ratio: 0.31140902873358867
Quick ratio: 0.2019443107018114
Interest coverage ratio: -7.176039646627882
COGS to revenue (%): 65.24851899804526
R&D to revenue (%): 11.708041183705678
SG&A to revenue (%): 27.643128238102694
Free cash flow (dilution-adjusted): -32853287.67123288
Retained earnings: -621730410.9589041
Inventory turnover: 1.5268670765267514
Receivables turnover: 3.1916011854843087
Capitalized R&D asset: 95143146.41868418
Rosenberg metric: 0.41093768932116165
FCF margin (%): -9.955496259668388
Revenue growth (%): 9.490930568266219
Rule of 40 score: -0.46456569140216963
Financial ratios for 2590.HK — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -857717123.2876712
Buffett classification: The Gruesome
Shares outstanding: 1005950483
Book value: -855999863.0136988
Debt to equity: -0.07171586091983434
Current ratio: 0.31140902873358867
Quick ratio: 0.2019443107018114
Retained earnings: -621730410.9589041
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 2590.HK — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -879288702.9288703
Buffett classification: The Gruesome
Shares outstanding: 1005950483
Book value: -877577405.8577406
Debt to equity: -0.0936183197371997
Current ratio: 0.3393943586434312
Quick ratio: 0.19447089382644944
Retained earnings: -639691492.3291492
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 304A.T — annual report dated 2023-02-28
Total revenue: 15743661.971830986
Gross profit: 7522637.910798122
Operating income: 750652.8755868545
Net income: 954027.2887323945
Capital expenditures: 108934.85915492958
Operating cash flow: -1830809.8591549296
Depreciation & amortization: 399567.19483568077
Net tangible assets: 9094857.687793428
Owner earnings: 1244659.6244131455
Return on net tangible assets (%): 13.685311712833649
Capex to operating income (%): 14.512015166766018
Buffett classification: The Great
Shares outstanding: 1231900
Book value: 9793265.845070422
Debt to equity: 0
Current ratio: 6.987027211077377
Quick ratio: 6.987027211077377
Effective tax rate (%): 12.234871746421655
COGS to revenue (%): 52.21794484702094
Free cash flow (dilution-adjusted): -2161583.039906103
Retained earnings: 9059697.769953052
Receivables turnover: 4.590456227407866
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.664990284775188
FCF margin (%): -13.729861856623128
Rule of 40 score: -13.729861856623128
Financial ratios for 304A.T — annual report dated 2024-02-29
Total revenue: 12922779.76901633
Gross profit: 6987455.197132616
Operating income: 923642.6390548254
Net income: 657679.5433426258
Capital expenditures: 65385.63653258994
Operating cash flow: 3448241.0726138325
Depreciation & amortization: 294743.1302270012
Net tangible assets: 8616354.705960441
Owner earnings: 887037.0370370372
Return on net tangible assets (%): 10.294806415332708
Capex to operating income (%): 7.0791054643709215
Buffett classification: The Great
Shares outstanding: 1231900
Book value: 9518817.204301074
Debt to equity: 0
Current ratio: 6.807731302155093
Quick ratio: 6.807731302155093
Effective tax rate (%): 29.392734476320776
COGS to revenue (%): 45.929111541871215
Free cash flow (dilution-adjusted): 2910832.3377140583
Retained earnings: 8855071.02084163
Receivables turnover: 12.719401054426436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.703334135227198
FCF margin (%): 22.5248157884194
Revenue growth (%): -17.9175734836143
Rule of 40 score: 4.607242304805098
Financial ratios for AMNPLST.NS — annual report dated 2022-03-31
Total revenue: 74270433.86522485
Gross profit: 13586733.482790453
Operating income: 4718172.227350653
Net income: 3146169.0623763683
Capital expenditures: 1083977.3176842937
Operating cash flow: -3502571.5416062246
Depreciation & amortization: 579414.479757352
Net tangible assets: 21394434.920216274
Owner earnings: 2641606.224449427
Return on net tangible assets (%): 12.347165205813827
Capex to operating income (%): 22.97451778891438
Buffett classification: The Great
Shares outstanding: 55020000
Book value: 21398035.078464985
Debt to equity: 0.4442266886805419
Current ratio: 1.9123945377054887
Quick ratio: 1.1598243019918242
Effective tax rate (%): 25.841215764655416
Interest coverage ratio: 4.06479282882105
COGS to revenue (%): 81.70640350984661
SG&A to revenue (%): 6.099652925188838
Free cash flow (dilution-adjusted): -4602373.730713438
Retained earnings: 19746577.871554796
Inventory turnover: 5.318406666435513
Receivables turnover: 5.505342656303612
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.343012942375566
FCF margin (%): -6.196777763632235
Rule of 40 score: -6.196777763632235
Financial ratios for AMNPLST.NS — annual report dated 2023-03-31
Total revenue: 72751193.66626066
Gross profit: 12952387.332521316
Operating income: 4584141.291108404
Net income: 2785883.0694275275
Capital expenditures: 264872.10718635813
Operating cash flow: 551619.9756394641
Depreciation & amortization: 588830.694275274
Net tangible assets: 22243398.294762485
Owner earnings: 3109841.6565164435
Return on net tangible assets (%): 13.980964667834495
Capex to operating income (%): 5.778009235887108
Buffett classification: The Great
Shares outstanding: 55020000
Book value: 22246723.507917173
Debt to equity: 0.4642482490681408
Current ratio: 1.959517820011342
Quick ratio: 1.3831281392324948
Effective tax rate (%): 24.488603349004276
Interest coverage ratio: 3.722373327267152
COGS to revenue (%): 82.19632327692217
SG&A to revenue (%): 5.179115645017063
Free cash flow (dilution-adjusted): 284884.287454324
Retained earnings: 20715554.202192448
Inventory turnover: 6.518693096493476
Receivables turnover: 4.9170982493836
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.642859118424266
FCF margin (%): 0.3915870971976133
Revenue growth (%): -2.045551802916742
Rule of 40 score: -1.6539647057191287
Financial ratios for AURIONPRO.NS — annual report dated 2023-03-31
Total revenue: 80308355.6638246
Gross profit: 50109756.394640684
Operating income: 16581534.713763705
Net income: 12409951.278928136
Capital expenditures: 5594786.845310598
Operating cash flow: 4979963.459196103
Depreciation & amortization: 1930572.4725943971
Net tangible assets: 46301900.12180268
Owner earnings: 8745736.906211935
Return on net tangible assets (%): 18.888505403029313
Capex to operating income (%): 33.74106765079216
Buffett classification: The Good
Shares outstanding: 55213530
Book value: 62734628.50182705
Debt to equity: 0.17145379499090674
Current ratio: 1.9540748446074732
Quick ratio: 1.855895475428661
Effective tax rate (%): 16.706970128022757
Interest coverage ratio: 16.59002169197397
COGS to revenue (%): 37.60330916946799
SG&A to revenue (%): 2.3900871731310924
Free cash flow (dilution-adjusted): -614823.3861144945
Retained earnings: 49753982.947624855
Inventory turnover: 8.862510366324457
Receivables turnover: 2.874319817600823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.149833761274024
FCF margin (%): -0.765578352379895
Rule of 40 score: -0.765578352379895
Financial ratios for AURIONPRO.NS — annual report dated 2024-03-31
Total revenue: 106424211.53615542
Gross profit: 70769540.71231562
Operating income: 20972682.575848423
Net income: 17139549.106607508
Capital expenditures: 3876460.007195107
Operating cash flow: 19621729.224127594
Depreciation & amortization: 2474193.5483870967
Net tangible assets: 66794471.75920374
Owner earnings: 15737282.647799496
Return on net tangible assets (%): 23.560756202299068
Capex to operating income (%): 18.48337709387322
Buffett classification: The Great
Shares outstanding: 55213530
Book value: 113425362.75332773
Debt to equity: 0.08590056331098
Current ratio: 2.198991461300887
Quick ratio: 2.118105822911603
Effective tax rate (%): 15.315342538477218
Interest coverage ratio: 18.21138346835496
COGS to revenue (%): 33.50240542935745
SG&A to revenue (%): 2.3696084888359796
Free cash flow (dilution-adjusted): 14454179.158172442
Retained earnings: 65167010.43290562
Inventory turnover: 9.02445783315375
Receivables turnover: 2.7937357239454923
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 17.654933368705546
FCF margin (%): 13.581664312600457
Revenue growth (%): 32.51947528555221
Rule of 40 score: 46.10113959815267
Financial ratios for AURIONPRO.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 105497467.74964166
Buffett classification: The Gruesome
Shares outstanding: 55213530
Book value: 165407728.1414238
Debt to equity: 0.023060261331382625
Current ratio: 3.25492019394792
Quick ratio: 3.145532880140825
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AURIONPRO.NS — quarterly report dated 2024-12-31
Total revenue: 35681862.68795897
Gross profit: 22871395.267513696
Operating income: 6570579.321599253
Net income: 5572351.089870614
Capital expenditures: 0
Depreciation & amortization: 868597.7386641799
Owner earnings: 6440948.828534794
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 55213530
Effective tax rate (%): 19.250428196439977
Interest coverage ratio: 37.13372859025033
COGS to revenue (%): 35.901902130149246
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AURIONPRO.NS — annual report dated 2025-03-31
Total revenue: 137124982.46434414
Gross profit: 89913935.00116904
Operating income: 25170224.45639467
Net income: 22028057.049333643
Capital expenditures: 11128875.37993921
Operating cash flow: 18365910.68505962
Depreciation & amortization: 3512777.647884031
Net tangible assets: 106357762.45031564
Owner earnings: 14411959.317278463
Return on net tangible assets (%): 13.550453662478015
Capex to operating income (%): 44.2144463161982
Buffett classification: The Good
Shares outstanding: 55213530
Book value: 176336170.21276593
Debt to equity: 0.020222429420286514
Current ratio: 2.9542465391295836
Quick ratio: 2.8669565164201356
Effective tax rate (%): 16.07368461993285
Interest coverage ratio: 32.40951033371969
COGS to revenue (%): 34.42920948081153
SG&A to revenue (%): 2.502772669412467
Free cash flow (dilution-adjusted): 7190659.340659341
Retained earnings: 83422609.30558802
Inventory turnover: 12.30404301992566
Receivables turnover: 3.8344488307381694
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.680190355758109
FCF margin (%): 5.243872568974868
Revenue growth (%): 28.84754369804166
Rule of 40 score: 34.09141626701653
Financial ratios for AURIONPRO.NS — quarterly report dated 2025-03-31
Total revenue: 38222363.80640636
Gross profit: 24525754.03320084
Operating income: 6693488.4264671495
Net income: 5904290.390460603
Capital expenditures: 0
Depreciation & amortization: 1015010.5213935
Net tangible assets: 106357762.45031564
Owner earnings: 6919300.911854103
Return on net tangible assets (%): 6.505684918941776
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 55213530
Book value: 176336170.21276593
Debt to equity: 0.020222429420286514
Current ratio: 2.9542465391295836
Quick ratio: 2.8669565164201356
Effective tax rate (%): 14.121780328975287
Interest coverage ratio: 34.84638792526322
COGS to revenue (%): 35.83402073869084
Retained earnings: 83422609.30558802
Inventory turnover: 3.5695813783437935
Receivables turnover: 1.0099108713480187
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.637957062193416
Revenue growth (%): 7.119866865315556
Rule of 40 score: 7.119866865315556
Financial ratios for AURIONPRO.NS — quarterly report dated 2025-06-30
Total revenue: 39412719.40088931
Gross profit: 27195892.815352213
Operating income: 6801439.26983384
Net income: 6004048.677743974
Capital expenditures: 0
Depreciation & amortization: 1175005.8506903816
Owner earnings: 7179054.528434356
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 55213530
Effective tax rate (%): 15.306892174195196
Interest coverage ratio: 34.13501291989664
COGS to revenue (%): 30.997167338982027
Capitalized R&D asset: 0
Revenue growth (%): 3.1142908913536065
Rule of 40 score: 3.1142908913536065
Financial ratios for AURIONPRO.NS — quarterly report dated 2025-12-31
Total revenue: 41330633.84204077
Gross profit: 27749036.426423084
Operating income: 7203765.177676284
Net income: 4894463.629274813
Capital expenditures: 0
Depreciation & amortization: 1195009.4686420853
Owner earnings: 6089473.097916899
Capex to operating income (%): 0
Buffett classification: The Great
Shares outstanding: 55213530
Effective tax rate (%): 22.22938098710714
Interest coverage ratio: 31.662847630238936
COGS to revenue (%): 32.86084957594513
Capitalized R&D asset: 0
Revenue growth (%): 4.86623219687852
Rule of 40 score: 4.86623219687852
Financial ratios for AURR.L — annual report dated 2021-12-31
Total revenue: 7118918.918918919
Gross profit: 2462162.1621621624
Operating income: 271621.6216216216
Net income: 97297.2972972973
Capital expenditures: 21621.621621621623
Operating cash flow: 443243.24324324325
Depreciation & amortization: 254498.64864864864
Net tangible assets: -1175675.6756756757
Owner earnings: 330174.3243243243
Return on net tangible assets (%): -28.083793103448272
Capex to operating income (%): 7.9601990049751254
Buffett classification: The Great
Shares outstanding: 89370833
Book value: 4762162.162162161
Debt to equity: 0.08399545970488083
Current ratio: 2.8164556962025316
Quick ratio: 2.2009493670886076
Effective tax rate (%): 59.55056179775281
Interest coverage ratio: 8.739130434782608
COGS to revenue (%): 65.41381928625664
SG&A to revenue (%): 33.95975702353835
Free cash flow (dilution-adjusted): -1206756.7567567567
Retained earnings: 4762162.162162162
Inventory turnover: 4.4293059125964005
Receivables turnover: 6.527881040892193
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.9004329004329006
FCF margin (%): -16.951404707668942
Rule of 40 score: -16.951404707668942
Financial ratios for BORANA.NS — annual report dated 2022-03-31
Capital expenditures: 0
Net tangible assets: 238507.18712910457
Buffett classification: The Gruesome
Shares outstanding: 26645295
Book value: 238507.1871291045
Debt to equity: 15.375704965166433
Current ratio: 1.2597333674935265
Quick ratio: 0.917969786529294
Retained earnings: 237188.44784386127
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BORANA.NS — annual report dated 2023-03-31
Total revenue: 16491961.023142511
Gross profit: 4373361.753958588
Operating income: 2694104.750304507
Net income: 1985493.3008526189
Capital expenditures: 2669110.84043849
Operating cash flow: 839951.2789281365
Depreciation & amortization: 497612.66747868457
Net tangible assets: 2936686.9671132765
Owner earnings: -186004.87210718635
Return on net tangible assets (%): -6.333833813074964
Capex to operating income (%): 99.07227401372599
Buffett classification: The Gruesome
Shares outstanding: 26645295
Book value: 2936686.967113277
Debt to equity: 1.6893804282005125
Current ratio: 1.2048365770009504
Quick ratio: 0.5066147404377229
Effective tax rate (%): 18.076461098518923
Interest coverage ratio: 10.005699810006334
COGS to revenue (%): 73.48185732538644
SG&A to revenue (%): 0.31529036403518484
Free cash flow (dilution-adjusted): -1829159.5615103533
Retained earnings: 2204567.600487211
Inventory turnover: 4.90667843686505
Receivables turnover: 18.26162602503237
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 48.15059114469384
FCF margin (%): -11.091219285223671
Rule of 40 score: -11.091219285223671
Financial ratios for BORANA.NS — annual report dated 2024-03-31
Total revenue: 23870440.100731503
Gross profit: 7211656.0738697685
Operating income: 3846324.4993404485
Net income: 2828456.6494783545
Capital expenditures: 5803873.366111045
Operating cash flow: 2654107.2070991728
Depreciation & amortization: 1097529.679817724
Net tangible assets: 5719702.602230484
Owner earnings: -1877887.0368149662
Return on net tangible assets (%): -32.83189996771259
Capex to operating income (%): 150.8940123774338
Buffett classification: The Gruesome
Shares outstanding: 26645295
Book value: 5719702.602230484
Debt to equity: 1.483860484814431
Current ratio: 1.322845721980682
Quick ratio: 0.7279378452589239
Effective tax rate (%): 16.926479807834546
Interest coverage ratio: 7.676998563906175
COGS to revenue (%): 69.78834054404899
SG&A to revenue (%): 0.48137304351146104
Free cash flow (dilution-adjusted): -3152884.0388535797
Retained earnings: 4998908.742055402
Inventory turnover: 5.844806186547289
Receivables turnover: 18.024847420178567
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 33.03176041688122
FCF margin (%): -13.208319685555193
Revenue growth (%): 44.73985275150157
Rule of 40 score: 31.53153306594638
Financial ratios for BORANA.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 7812446.249402772
Buffett classification: The Gruesome
Shares outstanding: 26645295
Book value: 7812446.249402771
Debt to equity: 0.9753599833653896
Current ratio: 2.1842181708323167
Quick ratio: 1.4422018490760429
Retained earnings: 4741113.234591495
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BORANA.NS — quarterly report dated 2024-12-31
Capital expenditures: 55799.044177643074
Operating cash flow: 1162466.4879356567
Depreciation & amortization: 375708.1244900338
Net tangible assets: 8953013.171698332
Buffett classification: The Gruesome
Shares outstanding: 26645295
Book value: 8953013.171698332
Debt to equity: 0.7236273872869848
Current ratio: 2.185579911612102
Quick ratio: 1.2920740894848664
Free cash flow (dilution-adjusted): 1096176.7105723277
Retained earnings: 5955787.387807436
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BORANA.NS — quarterly report dated 2025-03-31
Total revenue: 9199812.953004442
Gross profit: 3497615.15080664
Operating income: 1626595.744680851
Net income: 1273801.7301847087
Capital expenditures: 98339.95791442599
Operating cash flow: -365887.3041851765
Depreciation & amortization: 373041.85176525597
Owner earnings: 1548503.6240355386
Capex to operating income (%): 6.045752808342736
Buffett classification: The Great
Shares outstanding: 26645295
Effective tax rate (%): 19.28456079529461
Interest coverage ratio: 12.586069651741294
COGS to revenue (%): 61.981671054905505
Free cash flow (dilution-adjusted): -484931.0264203881
Capitalized R&D asset: 0
FCF margin (%): -5.271096585306346
Rule of 40 score: -5.271096585306346
Financial ratios for BORANA.NS — annual report dated 2025-03-31
Total revenue: 33938555.06195931
Gross profit: 13160170.680383446
Operating income: 5858837.970540098
Net income: 4699848.024316109
Capital expenditures: 834510.1706803833
Operating cash flow: 2646750.0584521857
Depreciation & amortization: 1526806.1725508533
Owner earnings: 5392144.026186579
Capex to operating income (%): 14.243612383147267
Buffett classification: The Great
Shares outstanding: 26645295
Effective tax rate (%): 18.159018132146645
Interest coverage ratio: 9.923273404086807
COGS to revenue (%): 61.223538667577884
Free cash flow (dilution-adjusted): 1481038.1108253447
Capitalized R&D asset: 0
FCF margin (%): 4.363880866823924
Revenue growth (%): 42.178170652661215
Rule of 40 score: 46.54205151948514
Financial ratios for CVS.TO — annual report dated 2022-12-31
Total revenue: 237108088235.2941
Gross profit: 40075000000
Operating income: 11977941176.470587
Net income: 3181617647.058823
Capital expenditures: 2005147058.8235292
Operating cash flow: 11894852941.17647
Depreciation & amortization: 3105882352.9411764
Net tangible assets: -23150000000
Owner earnings: 4282352941.1764708
Return on net tangible assets (%): -18.498284843094908
Capex to operating income (%): 16.740331491712706
Buffett classification: The Great
Shares outstanding: 7007849222
Book value: 52771323529.41177
Debt to equity: 0.9855508645794142
Current ratio: 0.945434378646231
Quick ratio: 0.6704455424151193
Effective tax rate (%): 25.856751199451683
Interest coverage ratio: 7.122868386532575
COGS to revenue (%): 83.0984255753302
Free cash flow (dilution-adjusted): 9561029411.764704
Retained earnings: 41469117647.05882
Inventory turnover: 14.036930330015714
Receivables turnover: 11.822371315442147
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.254699283618919
FCF margin (%): 4.0323505971153635
Rule of 40 score: 4.0323505971153635
Financial ratios for CVS.TO — annual report dated 2023-12-31
Total revenue: 271042424242.42422
Gross profit: 41235606060.60606
Operating income: 11059848484.848484
Net income: 6339393939.393939
Capital expenditures: 2296212121.212121
Operating cash flow: 10171212121.21212
Depreciation & amortization: 3307575757.5757575
Net tangible assets: -33367424242.42424
Owner earnings: 7350757575.757575
Return on net tangible assets (%): -22.029742309002156
Capex to operating income (%): 20.761696006575793
Buffett classification: The Great
Shares outstanding: 7007849222
Book value: 58057575757.57576
Debt to equity: 1.0358708700871653
Current ratio: 0.8569119448408238
Quick ratio: 0.6292919471138667
Effective tax rate (%): 25.10516423520988
Interest coverage ratio: 5.492475545522949
COGS to revenue (%): 84.78629086355708
Free cash flow (dilution-adjusted): 7429545454.545455
Retained earnings: 46669696969.69697
Inventory turnover: 16.829126213592232
Receivables turnover: 10.156300564907598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.560505221679497
FCF margin (%): 2.741100576897277
Revenue growth (%): 14.311758092982222
Rule of 40 score: 17.052858669879498
Financial ratios for CVS.TO — annual report dated 2024-12-31
Total revenue: 260705594405.59442
Gross profit: 35944755244.75525
Operating income: 6779720279.72028
Net income: 3226573426.5734267
Capital expenditures: 1944755244.7552447
Operating cash flow: 6368531468.531468
Depreciation & amortization: 3214685314.6853147
Net tangible assets: -30094405594.405594
Owner earnings: 4496503496.503496
Return on net tangible assets (%): -14.941326827001278
Capex to operating income (%): 28.684889118102113
Buffett classification: The Good
Shares outstanding: 7007849222
Book value: 52958041958.04195
Debt to equity: 1.0949425590915096
Current ratio: 0.811320308714203
Quick ratio: 0.5973123426585825
Effective tax rate (%): 25.406636304489265
Interest coverage ratio: 3.277552400270453
COGS to revenue (%): 86.21251096405935
Free cash flow (dilution-adjusted): 4046153846.1538467
Retained earnings: 43941958041.958046
Inventory turnover: 17.750483238526538
Receivables turnover: 10.22262743700129
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.750091930299041
FCF margin (%): 1.5520011587703089
Revenue growth (%): -3.813731324799691
Rule of 40 score: -2.2617301660293823
Financial ratios for CVS.TO — quarterly report dated 2025-03-31
Total revenue: 66145454545.45455
Gross profit: 10067132867.132868
Operating income: 2359440559.4405594
Net income: 1246153846.1538463
Capital expenditures: 519580419.5804196
Operating cash flow: 3186013986.013986
Depreciation & amortization: 806993006.9930071
Net tangible assets: -28562237762.237762
Owner earnings: 1533566433.566434
Return on net tangible assets (%): -5.369209675839782
Capex to operating income (%): 22.02133965619443
Buffett classification: The Great
Shares outstanding: 7007849222
Book value: 53923076923.07692
Debt to equity: 1.0532097004279601
Current ratio: 0.822731309225391
Quick ratio: 0.627308595901575
Effective tax rate (%): 31.90676346962171
Interest coverage ratio: 4.298089171974522
COGS to revenue (%): 84.78031039878208
Free cash flow (dilution-adjusted): 2578321678.3216786
Retained earnings: 44593006993.006996
Inventory turnover: 4.612712108139201
Receivables turnover: 2.3870788643533123
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.024918379105051
FCF margin (%): 3.8979574576056155
Rule of 40 score: 3.8979574576056155
Financial ratios for CVS.TO — quarterly report dated 2025-06-30
Total revenue: 72200729927.0073
Gross profit: 9921897810.218977
Operating income: 1737956204.379562
Net income: 745255474.4525547
Capital expenditures: 443065693.4306569
Operating cash flow: 1384671532.8467152
Depreciation & amortization: 854744525.5474452
Net tangible assets: -29232116788.321167
Owner earnings: 1156934306.569343
Return on net tangible assets (%): -3.957750699161007
Capex to operating income (%): 25.4934901301974
Buffett classification: The Good
Shares outstanding: 7007849222
Book value: 56606569343.065674
Debt to equity: 1.0667044912380244
Current ratio: 0.8033920265075084
Quick ratio: 0.6181049680338141
Effective tax rate (%): 38.49423193685488
Interest coverage ratio: 3.120576671035387
COGS to revenue (%): 86.25789819542031
Free cash flow (dilution-adjusted): 842335766.4233576
Retained earnings: 46668613138.68613
Inventory turnover: 4.890353642460021
Receivables turnover: 2.4332734742072764
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4502287109957914
FCF margin (%): 1.166658241924885
Revenue growth (%): 9.154484496575064
Rule of 40 score: 10.32114273849995
Financial ratios for CVS.TO — quarterly report dated 2025-09-30
Total revenue: 74007913669.06476
Gross profit: 9932374100.719425
Operating income: 1811510791.3669066
Net income: -2859712230.2158275
Capital expenditures: 502158273.381295
Operating cash flow: 572661870.5035971
Depreciation & amortization: 815827338.1294965
Net tangible assets: -27722302158.273384
Owner earnings: -2546043165.467626
Capex to operating income (%): 27.720413026211276
Buffett classification: The Good
Shares outstanding: 7007849222
Book value: 52597122302.158295
Debt to equity: 1.11820544385173
Current ratio: 0.8318571659744323
Quick ratio: 0.6272938130427747
Interest coverage ratio: 3.2117346938775513
COGS to revenue (%): 86.57930806544117
Free cash flow (dilution-adjusted): -28776978.41726619
Retained earnings: 42523021582.73382
Inventory turnover: 4.697025630207785
Receivables turnover: 2.345600474268646
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.548280781150081
FCF margin (%): -0.03888365039709928
Revenue growth (%): 2.5029992686839475
Rule of 40 score: 2.4641156182868484
Financial ratios for IRMENERGY.NS — annual report dated 2023-03-31
Total revenue: 119290133.98294763
Gross profit: 22362606.577344704
Operating income: 11130085.261875762
Net income: 7691352.009744215
Capital expenditures: 19793666.260657735
Operating cash flow: 5683922.046285018
Depreciation & amortization: 2545432.3995127897
Net tangible assets: 41785261.87576127
Owner earnings: -9556881.851400731
Return on net tangible assets (%): -22.871417869333666
Capex to operating income (%): 177.83930486550372
Buffett classification: The Gruesome
Shares outstanding: 41059677
Book value: 42195736.90621194
Debt to equity: 0.8646699015954299
Current ratio: 2.404931191438104
Quick ratio: 2.3843685708499005
Effective tax rate (%): 24.13510389505658
Interest coverage ratio: 5.086729013582722
COGS to revenue (%): 81.25359924523062
SG&A to revenue (%): 0.47724460164268523
Free cash flow (dilution-adjusted): -14109744.214372717
Retained earnings: 30395615.10353228
Inventory turnover: 412.5324002073613
Receivables turnover: 25.35787892910776
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.070973592851287
FCF margin (%): -11.828089837160956
Rule of 40 score: -11.828089837160956
Financial ratios for LAFA — quarterly report dated 2024-09-30
Capital expenditures: 0
Operating cash flow: 0
Buffett classification: The Gruesome
Shares outstanding: 15713333
Free cash flow (dilution-adjusted): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAFA — annual report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -3129.166666666667
Buffett classification: The Gruesome
Shares outstanding: 15713333
Book value: -3129.166666666668
Debt to equity: 0
Current ratio: 0
Quick ratio: 0
Retained earnings: -8337.5
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAFA — quarterly report dated 2024-12-31
Capital expenditures: 0
Operating cash flow: 0
Buffett classification: The Gruesome
Shares outstanding: 15713333
Free cash flow (dilution-adjusted): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAFA — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: 0
Net income: 0
Capital expenditures: 0
Owner earnings: 0
Buffett classification: The Gruesome
Shares outstanding: 15713333
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAFA — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -12260
Net income: -12260
Capital expenditures: 0
Net tangible assets: -15794.117647058823
Owner earnings: -12260
Buffett classification: The Gruesome
Shares outstanding: 15713333
Book value: -15794.117647058825
Debt to equity: -1.2426070763500932
Quick ratio: 0
Retained earnings: -21676.470588235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for LAFA — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -51148.23529411765
Net income: -51148.23529411765
Capital expenditures: 0
Operating cash flow: -48490.58823529412
Net tangible assets: -66942.35294117648
Owner earnings: -51148.23529411765
Buffett classification: The Gruesome
Shares outstanding: 15713333
Book value: -66942.3529411765
Debt to equity: -2.6361575367743963
Current ratio: 0.02932108290495043
Quick ratio: 0.02932108290495043
Free cash flow (dilution-adjusted): -48490.58823529412
Retained earnings: -72824.70588235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NOWS.TO — annual report dated 2022-12-31
Total revenue: 5327205882.352941
Gross profit: 4170588235.2941175
Operating income: 261029411.76470587
Net income: 238970588.2352941
Capital expenditures: 404411764.7058823
Operating cash flow: 2002205882.352941
Depreciation & amortization: 318382352.9411765
Net tangible assets: 2923529411.7647057
Owner earnings: 152941176.4705882
Return on net tangible assets (%): 5.231388329979879
Capex to operating income (%): 154.92957746478874
Buffett classification: The Gruesome
Shares outstanding: 53139586104
Book value: 3699999999.999999
Debt to equity: 0.44356120826709067
Current ratio: 1.1080766028309743
Quick ratio: 1.1080766028309743
Effective tax rate (%): 18.546365914786968
Interest coverage ratio: 13.148148148148149
COGS to revenue (%): 21.71152518978606
R&D to revenue (%): 24.403036576949624
SG&A to revenue (%): 48.98550724637682
Free cash flow (dilution-adjusted): 567647058.8235294
Retained earnings: 248529411.76470587
Receivables turnover: 4.199999999999999
Capitalized R&D asset: 1300000000
ROCI (R&D-adjusted, %): 16.924152137129408
FCF margin (%): 10.655624568668047
Rule of 40 score: 10.655624568668047
Financial ratios for NOWS.TO — annual report dated 2023-12-31
Total revenue: 6796212121.212121
Gross profit: 5340909090.909091
Operating income: 577272727.2727273
Net income: 1311363636.3636363
Capital expenditures: 525757575.75757575
Operating cash flow: 2574242424.242424
Depreciation & amortization: 425757575.75757575
Net tangible assets: 4676515151.515151
Owner earnings: 1211363636.3636363
Return on net tangible assets (%): 25.90312651871051
Capex to operating income (%): 91.0761154855643
Buffett classification: The Gruesome
Shares outstanding: 53139586104
Book value: 5778787878.787878
Debt to equity: 0.2994231777661248
Current ratio: 1.055940257976918
Quick ratio: 1.055940257976918
Effective tax rate (%): -71.72619047619048
Interest coverage ratio: 31.750000000000004
COGS to revenue (%): 21.413443317355924
R&D to revenue (%): 23.676290268643406
SG&A to revenue (%): 46.4162300746851
Free cash flow (dilution-adjusted): 831060606.060606
Retained earnings: 1567424242.4242423
Receivables turnover: 4.406188605108055
Capitalized R&D asset: 2480090909.090909
ROCI (R&D-adjusted, %): 12.079075070774653
Rosenberg metric: 0.9002468120115181
FCF margin (%): 12.228291160405751
Revenue growth (%): 27.575548445113675
Rule of 40 score: 39.80383960551943
Financial ratios for NOWS.TO — annual report dated 2024-12-31
Total revenue: 7681118881.118881
Gross profit: 6081818181.818182
Operating income: 953846153.8461539
Net income: 996503496.5034965
Capital expenditures: 595804195.8041959
Operating cash flow: 2983916083.916084
Depreciation & amortization: 394405594.4055944
Net tangible assets: 5683216783.216784
Owner earnings: 795104895.1048951
Return on net tangible assets (%): 13.990402362495386
Capex to operating income (%): 62.46334310850441
Buffett classification: The Good
Shares outstanding: 53139586104
Book value: 6719580419.5804205
Debt to equity: 0.23706941409095636
Current ratio: 1.0991864082316343
Quick ratio: 1.0991864082316343
Effective tax rate (%): 18.00920598388953
Interest coverage ratio: 59.30434782608695
COGS to revenue (%): 20.821194464675894
R&D to revenue (%): 23.15185724690459
SG&A to revenue (%): 43.60888565185724
Free cash flow (dilution-adjusted): 1139160839.160839
Retained earnings: 2443356643.3566437
Receivables turnover: 4.9035714285714285
Capitalized R&D asset: 3285412587.412587
ROCI (R&D-adjusted, %): 10.002108854357896
Rosenberg metric: 0.46045197740113003
FCF margin (%): 14.830662782228696
Revenue growth (%): 13.020587705684134
Rule of 40 score: 27.85125048791283
Financial ratios for NOWS.TO — quarterly report dated 2025-03-31
Total revenue: 2159440559.4405594
Gross profit: 1704195804.1958044
Operating income: 315384615.3846154
Net income: 321678321.6783217
Capital expenditures: 143356643.35664335
Operating cash flow: 1172727272.7272727
Depreciation & amortization: 111888111.88811189
Net tangible assets: 6016783216.783217
Owner earnings: 290209790.2097902
Return on net tangible assets (%): 4.823337982333798
Capex to operating income (%): 45.454545454545446
Buffett classification: The Good
Shares outstanding: 53139586104
Book value: 7090209790.20979
Debt to equity: 0.2366111056317191
Current ratio: 1.1225478324049407
Quick ratio: 1.1225478324049407
Effective tax rate (%): 17.117117117117118
Interest coverage ratio: 75.16666666666667
COGS to revenue (%): 21.08160621761658
R&D to revenue (%): 22.76554404145078
SG&A to revenue (%): 41.5479274611399
Free cash flow (dilution-adjusted): 676923076.923077
Retained earnings: 2765034965.034965
Receivables turnover: 2.272259013980868
Capitalized R&D asset: 491608391.60839164
ROCI (R&D-adjusted, %): 6.8544880872524905
FCF margin (%): 31.347150259067362
Rule of 40 score: 31.347150259067362
Financial ratios for NOWS.TO — quarterly report dated 2025-06-30
Total revenue: 2346715328.467153
Gross profit: 1818248175.1824815
Operating income: 261313868.61313868
Net income: 281021897.81021893
Capital expenditures: 138686131.3868613
Operating cash flow: 522627737.22627735
Depreciation & amortization: 125547445.25547445
Net tangible assets: 6448905109.489051
Owner earnings: 267883211.67883208
Return on net tangible assets (%): 4.153933220147142
Capex to operating income (%): 53.07262569832402
Buffett classification: The Good
Shares outstanding: 53139586104
Book value: 7979562043.79562
Debt to equity: 0.2203622392974753
Current ratio: 1.0918187168922897
Quick ratio: 1.0918187168922897
Effective tax rate (%): 18.259023354564757
Interest coverage ratio: 59.66666666666667
COGS to revenue (%): 22.519440124416796
R&D to revenue (%): 22.830482115085534
SG&A to revenue (%): 43.51477449455676
Free cash flow (dilution-adjusted): 19708029.197080314
Retained earnings: 3167153284.6715326
Receivables turnover: 1.8956367924528303
Capitalized R&D asset: 865144045.7352866
ROCI (R&D-adjusted, %): 4.225098143695432
Rosenberg metric: 0.23199842177944288
FCF margin (%): 0.8398133748055998
Revenue growth (%): 8.672374342876585
Rule of 40 score: 9.512187717682185